drugset / Trial / NCT01146509

An Evaluation Of The Efficacy And Safety Of Donepezil Hydrochloride (E2020) In Migraine Prophylaxis

NCT01146509

Phase 2 Completed 89 enrolled Eisai Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this extension study was to evaluate the safety and efficacy of donepezil hydrochloride after extended use in migraine prophylaxis. Efficacy will continue to be evaluated.

Timeline

Start
2003-01
Primary completion
2004-04
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule 10 mg Oral

Indications